OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 29,587 results

Filters: systemic targeted therapy

Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.
Chaitanya Divgi
Semin Nucl Med. Sep, 2011.41(5):369-73 Print
Source:PubMed
PMID: 21803187 doi:10.1053/j.semnuclmed.2011.05.004
Hypertension and QT interval prolongation associated with targeted systemic cancer therapies.
Olivia G Fahey, Jennifer K Piccolo, Jason J Bergsbaken, Elizabeth N Dow-Hillgartner
J Oncol Pharm Pract. Dec, 2020.26(8):1987-1996 Print-Electronic
Source:PubMed
PMID: 32951523 doi:10.1177/1078155220958462
Targeted therapy at the end of life in advanced cancer patients.
Thomas I Peng Soh, Yi-Ching Yuen, Catherine Teo, Siew-Woon Lim, Noreen Chan, Alvin Seng Cheong Wong
J Palliat Med. Sep, 2012.15(9):991-7 Print-Electronic
Source:PubMed
PMID: 22794792 doi:10.1089/jpm.2012.0050
Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell Carcinoma.
Hani Chanbour, Jeffrey W Chen, Gabriel A Bendfeldt, Lakshmi Suryateja Gangavarapu, Matthew E LaBarge, Mahmoud Ahmed, Iyan Younus, Soren Jonzzon, Steven G Roth, Silky Chotai, Brian I Rini, Leo Y Luo, Amir M Abtahi, Byron F Stephens, Scott L Zuckerman
Int J Spine Surg. Jul 04, 2024.18(3):343-352 Electronic
Source:PubMed
PMID: 38964886 doi:10.14444/8608
B-cell-targeted therapy in systemic vasculitis.
Lindsay Lally, Robert Spiera
Curr Opin Rheumatol. Jan, 2016.28(1):15-20 Print
Source:PubMed
PMID: 26599379 doi:10.1097/BOR.0000000000000235
Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
Amanda Yl Goh, Christopher J Layton
Clin Exp Ophthalmol. Aug, 2016.44(6):509-19 Print-Electronic
Source:PubMed
PMID: 26601795 doi:10.1111/ceo.12688
Cachexia is an independent predictor of mortality in patients with hepatocellular carcinoma on systemic targeted therapy.
Shinji Unome, Kenji Imai, Masashi Aiba, Takao Miwa, Tatsunori Hanai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu
Clin Nutr ESPEN. Apr, 2025.66:454-459 Print-Electronic
Source:PubMed
PMID: 39993564 doi:10.1016/j.clnesp.2025.02.018
Efficacy of first-line radiofrequency ablation combined with systemic chemotherapy plus targeted therapy for initially unresectable colorectal liver metastases.
Yaqing Kong, Xiaoyu Huang, Gang Peng, Xiaojing Cao, Xiang Zhou
Int J Hyperthermia. Dec, 2025.42(1):2432988 Print-Electronic
Source:PubMed
PMID: 39894452 doi:10.1080/02656736.2024.2432988
Surgical management of metastatic melanoma in the era of targeted systemic therapies.
D Peter O'Leary, Kevin G Byrnes, Derek G Power, H Paul Redmond
Melanoma Res. Feb, 2015.25(1):1-8 Print
Source:PubMed
PMID: 25532830 doi:10.1097/CMR.0000000000000128
Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
Katiuscha Merath, Ankur Tiwari, Alexander A Parikh, Timothy M Pawlik
Future Oncol. Dec, 2023.19(39):2607-2621 Print-Electronic
Source:PubMed
PMID: 38108100 doi:10.2217/fon-2023-0098
0